Lactimidomycin,134869-15-1

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Lactimidomycin

CAS No. : 134869-15-1

MCE 国际站：Lactimidomycin

产品活性：Lactimidomycin 是从链霉菌中分离出的含戊二酰亚胺的化合物。Lactimidomycin 是一种有效的真核翻译延伸抑制剂，对肿瘤细胞系具有有效的抗增殖作用，并选择性抑制蛋白质翻译。Lactimidomycin 抑制蛋白质合成，IC₅₀ 值为 37.82 nM。Lactimidomycin 还是登革热病毒 2 和其他 RNA 病毒的有效且无毒的抑制剂。抗癌和抗病毒活性。

研究领域：Anti-infection

作用靶点：Flavivirus

In Vitro: Lactimidomycin (0.01-100 nM; 24 hours; Hs 579T, HCC 1937, HCC 1395, HCC 2218, BT 474, MCF 7, MDA MB231 cells and MCF 10A) treatment inhibits cell growth with IC₅₀ concentrations in the low nanomolar range, but higher doses are necessary to inhibit growth of the non-tumorigenic breast cell line MCF10A.
Lactimidomycin induces a clear dose-responsive inhibition of DENV2 infectious particle production with an EC₉₀ value of 0.4 μM. No measurable decrease in cell viability was detected at concentrations up to 12.5 µM.
Lactimidomycin is a potent inhibitor of DENV2 and Lactimidomycin's inhibition of DENV2 translation leads to reduced production of newly infectious particles. Lactimidomycin may protect cells from viral cytopathic effects including apoptosis, likely through inhibition of virus protein production and replication.

In Vivo: Lactimidomycin (0.6 mg/kg; intraperitoneal injection; daily; for one month; female nude mice) treatment has an appreciable effect on tumor growth in nude mice.

相关产品：Emricasan  |  Ivermectin  |  U18666A  |  Mycophenolic acid  |  ML-SA1  |  Quinine  |  FR 180204  |  Lanatoside C  |  Loratadine  |  NITD008  |  (+)-JNJ-A07  |  Merimepodib  |  ZCL278  |  Nanchangmycin  |  QL47  |  KIN1408  |  Merbromin  |  SN 2  |  T-1105  |  HeE1-2Tyr  |  Mosnodenvir  |  Cephaeline  |  ABMA  |  Celgosivir hydrochloride  |  Cyclofenil  |  NITD-688  |  IHVR-19029

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds